Email not displaying properly? View email in your browser
e-Newsletter
Advertise | Archives
www.pharmaceutical-tech.com
News
Alexion Pharmaceuticals invests €450 million for biologics manufacturing facility in Dublin creating 200 jobs

Mylan mulls over reducing risk in cash-and-stock offer for Perrigo

Moberg Pharma Q1 performance beats expectations

Pfizer buys $87.5 million equity interest, poised to acquire AM-Pharma on phase 2 trial completion of RecAP for about $512.5 million

Events
May 14th - May 16th
RadiologyAsia 2015


May 18th - May 19th
Formulation & Drug Delivery Congress

May 27th - May 28th
Pharma Exabyte

Articles    
Drugs Shortage and its Impact on Counterfeit Drugs

Drugs Shortage Though the word shortage refers to the availability of less its presence is not clinging to its meaning by swirling around the world with a strong presence yet another area shadowing...
Read More»»

Projects    
S Korean biopharma company Green Cross to build Cell Therapy manufacturing facility in China

Green Cross, a South Korean biopharmaceutical company, today announced plans to build a new cell therapy manufacturing facility at the Guian New Area in the Guizhou province of China. Features: The new manufacturing site sets to address the cellular therapeutic industry’s dema...
More»»

Featured Products    
Advanced Isolator Technology
Increased product safety by reducing the risk of contamination with no direct contact between operators...
Bioprocess Solutions
Sartorius helps its customers to develop and manufacture biotech medicines reliably, quickly, and economically...
Micro Proteomics Analysis
The Microproteomics analysis provides ultimate proteomic sensitivity lowfemtomolar...
Partners    
Advertise With Us | Company Registration | Subscribe| Unsubscribe pharmaceutical-tech.com
www.pharmaceutical-tech.com – a product of Ochre Media Pvt. Ltd.
Ochre Media Pvt Ltd. Media Resource Centre, 2nd Floor, Oxford Plaza, Secunderabad - 500 003, Telangana, India
Tel: +91 40 4961 4567 I Fax: +91 40 4961 4555
Facebook Twitter Linkdin